HC Wainwright Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: HC Wainwright
Rating: 0
Author: MarketBeat

View the latest stock recommendations issued by analysts at HC Wainwright. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from HC Wainwright's equity research team. MarketBeat is not affiliated with or endorsed by HC Wainwright.

36 Analysts
Updated 7/24/2026

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 2,028 Last 12 Months
Buy Ratings: 1,869 Last 12 Months
Sell Ratings: 13 Last 12 Months
Companies Covered: 644 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
LQDA Liquidia	$86.22	7/24/2026	Andrew S. Fein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$36.00		View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 7/24/2026
NVCR NovoCure	$17.65	7/24/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$32.00		View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 7/24/2026
ITGR Integer	$98.61 0.0%	7/24/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Integer (NYSE:ITGR) on 7/24/2026
PRTA Prothena	$8.75	7/24/2026		Reiterated Rating	$30.00	Buy	View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 7/24/2026
LBRX LB Pharmaceuticals	$35.01	7/24/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of LB Pharmaceuticals (NASDAQ:LBRX) on 7/24/2026
TEM Tempus AI	$42.69	7/24/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Tempus AI (NASDAQ:TEM) on 7/24/2026
IMAX IMAX	$43.21 -0.4%	7/24/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of IMAX (NYSE:IMAX) on 7/24/2026
LQDA Liquidia	$86.22	7/23/2026	Andrew S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$75.00 ➝ $130.00	Buy	View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 7/23/2026
MNKD MannKind	$4.13	7/23/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of MannKind (NASDAQ:MNKD) on 7/23/2026
IONS Ionis Pharmaceuticals	$56.55	7/23/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 7/23/2026
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
BLFS BioLife Solutions	$29.98	7/23/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$32.00 ➝ $31.00	Buy ➝ Neutral	View details for HC Wainwright rating of BioLife Solutions (NASDAQ:BLFS) on 7/23/2026
NVCR NovoCure	$17.65	7/23/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$46.00 ➝ $52.00	Buy	View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 7/23/2026
SMMT Summit Therapeutics	$13.66	7/23/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 7/23/2026
ASM Avino Silver & Gold Mines	$5.63	7/22/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$13.00 ➝ $10.25	Buy	View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 7/22/2026
PVLA Palvella Therapeutics	$138.01	7/22/2026	Andrew S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$270.00	Buy	View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 7/22/2026
BLTE Belite Bio	$153.36	7/22/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 7/22/2026
IREN IREN	$37.07	7/22/2026	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$85.00 ➝ $90.00	Buy	View details for HC Wainwright rating of IREN (NASDAQ:IREN) on 7/22/2026
DRTS Alpha Tau Medical	$12.50	7/22/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$15.00	Buy	View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 7/22/2026
MNPR Monopar Therapeutics	$109.87	7/22/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$105.00 ➝ $125.00	Buy	View details for HC Wainwright rating of Monopar Therapeutics (NASDAQ:MNPR) on 7/22/2026
AGIO Agios Pharmaceuticals	$36.36	7/21/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$54.00 ➝ $52.00	Buy	View details for HC Wainwright rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 7/21/2026
DMRA Damora Therapeutics, Inc. Common Stock	$28.82	7/21/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$45.00	Buy	View details for HC Wainwright rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 7/21/2026
GLSI Greenwich LifeSciences	$12.98	7/21/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$50.00 ➝ $69.00	Buy	View details for HC Wainwright rating of Greenwich LifeSciences (NASDAQ:GLSI) on 7/21/2026
HALO Halozyme Therapeutics	$81.93	7/21/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$95.00	Buy	View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 7/21/2026
INCY Incyte	$117.67	7/21/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$140.00	Buy	View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 7/21/2026
PYPD PolyPid	$3.90	7/21/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$13.00	Buy	View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 7/21/2026
OKUR OnKure Therapeutics	$4.12	7/20/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$21.00	Buy	View details for HC Wainwright rating of OnKure Therapeutics (NASDAQ:OKUR) on 7/20/2026
HYFT MindWalk	$1.36	7/20/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of MindWalk (NASDAQ:HYFT) on 7/20/2026
VYGR Voyager Therapeutics	$3.10	7/20/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 7/20/2026
ANNX Annexon	$5.22	7/20/2026		Reiterated Rating	$14.00	Buy	View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 7/20/2026
INSM Insmed	$106.92	7/20/2026	Andrew S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$220.00	Buy	View details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 7/20/2026
FRHC Freedom	$151.02	7/20/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Freedom (NASDAQ:FRHC) on 7/20/2026
AARD Aardvark Therapeutics	$6.32	7/20/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$6.00	Neutral	View details for HC Wainwright rating of Aardvark Therapeutics (NASDAQ:AARD) on 7/20/2026
ATAI Atai Beckley	$7.18	7/20/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$25.00 ➝ $7.50	Buy ➝ Neutral	View details for HC Wainwright rating of Atai Beckley (NASDAQ:ATAI) on 7/20/2026
FDMT 4D Molecular Therapeutics	$10.07	7/20/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$36.00	Buy	View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/20/2026
MLTX MoonLake Immunotherapeutics	$19.02	7/20/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$45.00	Buy	View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 7/20/2026
RCUS Arcus Biosciences	$28.41 0.0%	7/20/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$32.00 ➝ $45.00	Buy	View details for HC Wainwright rating of Arcus Biosciences (NYSE:RCUS) on 7/20/2026
SLGL Sol-Gel Technologies	$81.96	7/20/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$110.00	Buy	View details for HC Wainwright rating of Sol-Gel Technologies (NASDAQ:SLGL) on 7/20/2026
SLNH Soluna	$1.26	7/20/2026	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$4.00	Buy	View details for HC Wainwright rating of Soluna (NASDAQ:SLNH) on 7/20/2026
SOPH SOPHiA GENETICS	$5.72	7/20/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$12.00	Buy	View details for HC Wainwright rating of SOPHiA GENETICS (NASDAQ:SOPH) on 7/20/2026
TRVI Trevi Therapeutics	$17.53 -0.1%	7/20/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$21.00 ➝ $24.00	Buy	View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 7/20/2026
SPCX Warning - and Worst News for Stocks in 50 Years (Ad) Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits. Learn how to prepare your portfolio for what's coming next
BWAY Brainsway	$15.97	7/17/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00	Buy	View details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 7/17/2026
GLDG GoldMining	$0.83	7/17/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$3.75 ➝ $2.75	Buy	View details for HC Wainwright rating of GoldMining (NYSEAMERICAN:GLDG) on 7/17/2026
CBIO Crescent Biopharma	$16.30	7/16/2026	Mitchell Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of Crescent Biopharma (NASDAQ:CBIO) on 7/16/2026
LEGN Legend Biotech	$22.22	7/16/2026	Mitchell Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 7/16/2026
DRD DRDGOLD	$20.98 +0.2%	7/16/2026		Reiterated Rating	$35.00	Buy	View details for HC Wainwright rating of DRDGOLD (NYSE:DRD) on 7/16/2026
DC Dakota Gold	$4.65	7/16/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$10.50 ➝ $10.75	Buy	View details for HC Wainwright rating of Dakota Gold (NYSE:DC) on 7/16/2026
DRTS Alpha Tau Medical	$12.50	7/16/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$15.00	Buy	View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 7/16/2026
HRMY Harmony Biosciences	$35.32	7/16/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$55.00	Buy	View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 7/16/2026
UROY Uranium Royalty	$2.96	7/16/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$4.50	Buy	View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 7/16/2026
NB NioCorp Developments	$4.14	7/15/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of NioCorp Developments (NASDAQ:NB) on 7/15/2026
NXTC NextCure	$4.24	7/15/2026		Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 7/15/2026
PMN Promis Neurosciences	$12.20	7/15/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Promis Neurosciences (NASDAQ:PMN) on 7/15/2026
PRLD Prelude Therapeutics	$3.83	7/15/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 7/15/2026
SMMT Summit Therapeutics	$13.66	7/15/2026	Mitchell Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 7/15/2026
SPTX Seaport Therapeutics	$21.10	7/15/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$50.00	Buy	View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 7/15/2026
CELC Celcuity	$82.62	7/15/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$145.00 ➝ $155.00	Buy	View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 7/15/2026
EVO Evotec	$1.94	7/15/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$7.00 ➝ $4.00	Buy	View details for HC Wainwright rating of Evotec (NASDAQ:EVO) on 7/15/2026
UMAC Unusual Machines	$19.36	7/15/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$42.00	Buy	View details for HC Wainwright rating of Unusual Machines (NYSEAMERICAN:UMAC) on 7/15/2026
ANGO AngioDynamics	$13.59	7/15/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$16.00 ➝ $19.00	Buy	View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 7/15/2026
AXSM Axsome Therapeutics	$241.00	7/15/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$290.00	Buy	View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 7/15/2026
COCH Envoy Medical	$0.66	7/15/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$2.50	Buy	View details for HC Wainwright rating of Envoy Medical (NASDAQ:COCH) on 7/15/2026
CRVO CervoMed	$2.66	7/15/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of CervoMed (NASDAQ:CRVO) on 7/15/2026
SNDX Syndax Pharmaceuticals	$20.81	7/15/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$40.00	Buy	View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 7/15/2026
SPTX Seaport Therapeutics	$21.10	7/15/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$50.00	Buy	View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 7/15/2026
UMAC Unusual Machines	$19.36	7/15/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$42.00	Buy	View details for HC Wainwright rating of Unusual Machines (NYSEAMERICAN:UMAC) on 7/15/2026
CLSK Cleanspark	$14.52	7/14/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Cleanspark (NASDAQ:CLSK) on 7/14/2026
ONCY Oncolytics Biotech	$0.81	7/14/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 7/14/2026
ERAS Erasca	$19.11	7/14/2026	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 7/14/2026
MBOT Microbot Medical	$1.71	7/14/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 7/14/2026
BMRN BioMarin Pharmaceutical	$59.33	7/14/2026	Mitchell Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 7/14/2026
INCY Incyte	$117.67	7/14/2026	Mitchell Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 7/14/2026
CRDL Cardiol Therapeutics	$1.18	7/14/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 7/14/2026
LCTX Lineage Cell Therapeutics	$1.03	7/14/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 7/14/2026
AGEN Agenus	$5.98	7/13/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$23.00 ➝ $30.00	Buy	View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 7/13/2026
ALNY Alnylam Pharmaceuticals	$271.77	7/13/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$470.00 ➝ $485.00	Buy	View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/13/2026
APYX Apyx Medical	$3.92	7/13/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$7.00	Buy	View details for HC Wainwright rating of Apyx Medical (NASDAQ:APYX) on 7/13/2026
BBIO BridgeBio Pharma	$84.02	7/13/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$110.00 ➝ $120.00	Buy	View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 7/13/2026
COAG Hemab Therapeutics	$47.31	7/13/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$40.00 ➝ $52.00	Buy	View details for HC Wainwright rating of Hemab Therapeutics (NASDAQ:COAG) on 7/13/2026
OKYO OKYO Pharma	$1.55	7/13/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$7.00 ➝ $5.00	Buy	View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 7/13/2026
TGTX TG Therapeutics	$56.04	7/13/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$70.00 ➝ $77.00	Buy	View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 7/13/2026
TRAX First Tracks Biotherapeutics	$35.52	7/10/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$30.00 ➝ $44.00	Buy	View details for HC Wainwright rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 7/10/2026
NRIX Nurix Therapeutics	$23.38	7/10/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$32.00 ➝ $34.00	Buy	View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 7/10/2026
AG First Majestic Silver	$16.31 0.0%	7/10/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$30.75 ➝ $26.00	Buy	View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 7/10/2026
IONS Ionis Pharmaceuticals	$56.55	7/10/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$130.00 ➝ $125.00	Buy	View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 7/10/2026
URGN Urogen Pharma	$40.97	7/9/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 7/9/2026
IMNM Immunome	$22.21	7/9/2026	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Immunome (NASDAQ:IMNM) on 7/9/2026
RMTI Rockwell Medical	$6.63	7/9/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$2.00 ➝ $20.00	Buy	View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 7/9/2026
CRVO CervoMed	$2.66	7/9/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of CervoMed (NASDAQ:CRVO) on 7/9/2026
DTIL Precision BioSciences	$7.29	7/9/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 7/9/2026
ELVN Enliven Therapeutics	$52.95	7/9/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$56.00 ➝ $64.00	Buy	View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 7/9/2026
Iran War Shock: What I Was Told In That Private Meeting (Ad) You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country. Because THIS is the real reason.
EXK Endeavour Silver	$7.81 -0.2%	7/9/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$17.00	Buy	View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 7/9/2026
MSLE Satellos Bioscience	$9.78	7/9/2026	Arthur He Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$11.00 ➝ $18.00	Buy	View details for HC Wainwright rating of Satellos Bioscience (NASDAQ:MSLE) on 7/9/2026
NKLR Terra Innovatum Global S.R.L.	$5.05	7/9/2026	Sameer Joshi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	View details for HC Wainwright rating of Terra Innovatum Global S.R.L. (NASDAQ:NKLR) on 7/9/2026
PLYX Polaryx Therapeutics	$2.05	7/9/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$7.00	Buy	View details for HC Wainwright rating of Polaryx Therapeutics (NASDAQ:PLYX) on 7/9/2026
TARS Tarsus Pharmaceuticals	$58.66	7/9/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$88.00	Buy	View details for HC Wainwright rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 7/9/2026
AXSM Axsome Therapeutics	$241.00	7/8/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$290.00	Buy	View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 7/8/2026
CMPS Compass Pathways	$11.26	7/8/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$70.00	Buy	View details for HC Wainwright rating of Compass Pathways (NASDAQ:CMPS) on 7/8/2026
CRSP CRISPR Therapeutics	$46.54	7/8/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$80.00	Buy	View details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 7/8/2026
MGTX MeiraGTx	$11.77	7/8/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of MeiraGTx (NASDAQ:MGTX) on 7/8/2026
TII Titan Mining	$2.02	7/8/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$6.50	Buy	View details for HC Wainwright rating of Titan Mining (NYSEAMERICAN:TII) on 7/8/2026

MarketBeat Community Rating for HC Wainwright

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms in the last 90 days. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES: 0 Believe will outperform the market
UNDERPERFORM VOTES: 0 Believe will underperform the market

Analysts at HC Wainwright

HC Wainwright's equity research team has issued ratings on 637 companies across 17 sectors over the past 12 months, covered by 36 analysts. The HC Wainwright analysts below are listed by number of ratings issued in the last year.

HC Wainwright Stock Coverage by Sector

HC Wainwright concentrates its research most heavily in Medical (71.1%), Basic Materials (6.7%) and Computer and Technology (4.5%). The chart below shows how HC Wainwright's 644 rated companies are distributed across all 17 sectors it covers.

Medical
458 companies
71.1%
Basic Materials
43 companies
6.7%
Computer and Technology
29 companies
4.5%
Manufacturing
25 companies
3.9%
Finance
21 companies
3.3%
Business Services
21 companies
3.3%
Energy
13 companies
2.0%
Industrials
5 companies
0.8%
Financial Services
4 companies
0.6%
Aerospace
4 companies
0.6%
Consumer Discretionary
4 companies
0.6%
Construction
3 companies
0.5%
Retail/Wholesale
3 companies
0.5%
Transportation
2 companies
0.3%
Auto/Tires/Trucks
2 companies
0.3%
Consumer Staples
1 company
0.2%
Services
1 company
0.2%

Best & Worst Calls

Best Call
000000.0%
NASDAQ:NVAX
Initiated Coverage • Jan 22, 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
0000.0%
NASDAQ:EFTR
Reiterated Rating • Nov 14, 2023
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

HC Wainwright - Frequently Asked Questions

HC Wainwright's analysts currently have buy-equivalent ratings on 603 companies. Recent upgrades to buy include Prime Medicine, Zscaler, Circle Internet Group, BioStem Technologies and Airbnb.

HC Wainwright's highest-rated analysts by MarketBeat's accuracy score include Raghuram Selvaraju, Andrew Fein and Mitchell Kapoor. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 36 analysts at HC Wainwright.

HC Wainwright has the deepest coverage in Medical (71.1% of rated companies), Basic Materials (6.7% of rated companies), Computer and Technology (4.5% of rated companies), Manufacturing (3.9% of rated companies) and Business Services (3.3% of rated companies).

HC Wainwright issued 2,028 ratings over the last 12 months across 644 companies â€” an average of roughly 169 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current HC Wainwright analyst actions.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?